PD-L1 blockade restores CAR T cell activity through IFN-γ-regulation of CD163+ M2 macrophages

肿瘤微环境 癌症研究 免疫疗法 T细胞 嵌合抗原受体 CD14型 川地163 免疫系统 医学 细胞疗法 免疫学 细胞 巨噬细胞 生物 体外 遗传学 生物化学
作者
Yukiko Yamaguchi,Jackson Gibson,Kevin Ou,Lupita S. Lopez,Rachel H Ng,Neena A. Leggett,Vanessa D. Jönsson,Jelani C. Zarif,Peter P. Lee,Xiuli Wang,Catalina Martínez,Tanya Barauskas Dorff,Stephen J. Forman,Saul J. Priceman
出处
期刊:Journal for ImmunoTherapy of Cancer [BMJ]
卷期号:10 (6): e004400-e004400 被引量:149
标识
DOI:10.1136/jitc-2021-004400
摘要

Background The immune suppressive tumor microenvironment (TME) that inhibits T cell infiltration, survival, and antitumor activity has posed a major challenge for developing effective immunotherapies for solid tumors. Chimeric antigen receptor (CAR)-engineered T cell therapy has shown unprecedented clinical response in treating patients with hematological malignancies, and intense investigation is underway to achieve similar responses with solid tumors. Immunologically cold tumors, including prostate cancers, are often infiltrated with abundant tumor-associated macrophages (TAMs), and infiltration of CD163 + M2 macrophages correlates with tumor progression and poor responses to immunotherapy. However, the impact of TAMs on CAR T cell activity alone and in combination with TME immunomodulators is unclear. Methods To model this in vitro, we utilized a novel co-culture system with tumor cells, CAR T cells, and polarized M1 or M2 macrophages from CD14 + peripheral blood mononuclear cells collected from healthy human donors. Tumor cell killing, T cell activation and proliferation, and macrophage phenotypes were evaluated by flow cytometry, cytokine production, RNA sequencing, and functional blockade of signaling pathways using antibodies and small molecule inhibitors. We also evaluated the TME in humanized mice following CAR T cell therapy for validation of our in vitro findings. Results We observed inhibition of CAR T cell activity with the presence of M2 macrophages, but not M1 macrophages, coinciding with a robust induction of programmed death ligand-1 (PD-L1) in M2 macrophages. We observed similar PD-L1 expression in TAMs following CAR T cell therapy in the TME of humanized mice. PD-L1, but not programmed cell death protein-1, blockade in combination with CAR T cell therapy altered phenotypes to more M1-like subsets and led to loss of CD163 + M2 macrophages via interferon-γ signaling, resulting in improved antitumor activity of CAR T cells. Conclusion This study reveals an alternative mechanism by which the combination of CAR T cells and immune checkpoint blockade modulates the immune landscape of solid tumors to enhance therapeutic efficacy of CAR T cells.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
能干储完成签到,获得积分10
刚刚
1秒前
脑洞疼的应助被zzz采纳,获得10
1秒前
财务自由完成签到,获得积分10
1秒前
大大彬完成签到 ,获得积分10
1秒前
1秒前
科研通AI65的应助被SCL987654321采纳,获得10
1秒前
鱼卷发布了新的文献求助10
2秒前
顾矜的应助被mm采纳,获得10
2秒前
吴境发布了新的文献求助10
2秒前
今后的应助被JF123_采纳,获得10
2秒前
加菲丰丰的应助被yangfan采纳,获得30
3秒前
Li完成签到 ,获得积分10
3秒前
温柔的契完成签到,获得积分10
3秒前
4秒前
NN完成签到,获得积分10
4秒前
情怀的应助被王海钰采纳,获得10
4秒前
4秒前
蛋又白发布了新的文献求助10
4秒前
听话的老太完成签到,获得积分10
5秒前
英姑的应助被yanchen采纳,获得10
5秒前
5秒前
6秒前
黄油可颂完成签到,获得积分10
7秒前
7秒前
8秒前
坦率向薇完成签到,获得积分20
8秒前
财务自由发布了新的文献求助10
8秒前
9秒前
nanjincn发布了新的文献求助150
9秒前
xixilamn完成签到,获得积分10
9秒前
勿念那份执着完成签到,获得积分10
10秒前
吴呜呜发布了新的文献求助10
10秒前
10秒前
lee123发布了新的文献求助10
10秒前
Ezio_sunhao完成签到,获得积分10
11秒前
谨慎的破茧完成签到,获得积分10
11秒前
zzz发布了新的文献求助10
12秒前
12秒前
I7发布了新的文献求助10
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8187362
求助须知:如何正确求助?哪些是违规求助? 9575478
关于积分的说明 21841431
捐赠科研通 7785067
什么是DOI,文献DOI怎么找? 3434943
关于科研通互助平台的介绍 2559401
邀请新用户注册赠送积分活动 2481820